2929 Stock Overview
Engages in the development and sale of functional food ingredients in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Pharma Foods International Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥998.00 |
| 52 Week High | JP¥2,336.00 |
| 52 Week Low | JP¥800.00 |
| Beta | 1.38 |
| 11 Month Change | 14.71% |
| 3 Month Change | 10.28% |
| 1 Year Change | -54.45% |
| 33 Year Change | -62.55% |
| 5 Year Change | 107.48% |
| Change since IPO | 51.21% |
Recent News & Updates
Shareholder Returns
| 2929 | JP Biotechs | JP Market | |
|---|---|---|---|
| 7D | 1.3% | 0.06% | -0.6% |
| 1Y | -54.5% | -18.7% | 17.8% |
Return vs Industry: 2929 underperformed the JP Biotechs industry which returned -20.3% over the past year.
Return vs Market: 2929 underperformed the JP Market which returned 16.3% over the past year.
Price Volatility
| 2929 volatility | |
|---|---|
| 2929 Average Weekly Movement | 7.1% |
| Biotechs Industry Average Movement | 7.4% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in JP Market | 7.4% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 2929 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2929's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 670 | Yongsook Kim | www.pharmafoods.co.jp |
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. It also focuses on biomedical drug discovery of antibody, and peptide and diagnostics. Pharma Foods International Co., Ltd.
Pharma Foods International Co., Ltd. Fundamentals Summary
| 2929 fundamental statistics | |
|---|---|
| Market cap | JP¥28.02b |
| Earnings (TTM) | JP¥3.87b |
| Revenue (TTM) | JP¥63.21b |
7.2x
P/E Ratio0.4x
P/S RatioIs 2929 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2929 income statement (TTM) | |
|---|---|
| Revenue | JP¥63.21b |
| Cost of Revenue | JP¥12.94b |
| Gross Profit | JP¥50.28b |
| Other Expenses | JP¥46.41b |
| Earnings | JP¥3.87b |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 137.82 |
| Gross Margin | 79.54% |
| Net Profit Margin | 6.12% |
| Debt/Equity Ratio | 191.1% |
How did 2929 perform over the long term?
See historical performance and comparisonDividends
2.2%
Current Dividend Yield9%
Payout RatioDoes 2929 pay a reliable dividends?
See 2929 dividend history and benchmarks| Pharma Foods International dividend dates | |
|---|---|
| Ex Dividend Date | Jul 30 2024 |
| Dividend Pay Date | Oct 28 2024 |
| Days until Ex dividend | 38 days |
| Days until Dividend pay date | 128 days |
Does 2929 pay a reliable dividends?
See 2929 dividend history and benchmarks